US Patent 10301395 Chemically-locked bispecific antibodies
Patent 10301395 was granted and assigned to Sorrento Therapeutics on May, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 17, 2016
0
Date of Patent
May 28, 2019
0
Patent Applicant
Patent Application Number
15353979
0
Patent Inventor Names
Yanwen Fu
0
Gunnar F. Kaufmann
0
James T. Patterson
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10301395 Chemically-locked bispecific antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
